GET THE APP

Sensitive Quantitative Predictions of mhc Binding Peptides and Fr
Drug Designing: Open Access

Drug Designing: Open Access
Open Access

ISSN: 2169-0138

+44 1223 790975

Research Article - (2012) Volume 1, Issue 1

Sensitive Quantitative Predictions of mhc Binding Peptides and Fragment Based Peptide Vaccines From Trichinella spiralis

Gomase VS1* and Chitlange NR2
1Department of Bioinformatics, JJT University, Jhunjhunu Rajasthan, 333001, India, E-mail: gomase.viren@gmail.com
2School of Technology, S.R.T.M. University, Sub-Centre, Latur, 413531, MS, India, E-mail: gomase.viren@gmail.com
*Corresponding Author: Gomase VS, Department of Bioinformatics, JJT University, Jhunjhunu Rajasthan, 333001, India Email:

Abstract

Trichinella spiralis is a nematode parasite, occurring in rats, pigs, bears and humans, and is responsible for the disease trichinosis. Peptide fragments of antigen protein can be used to select nonamers for use in rational vaccine design and to increase the understanding of roles of the immune system in infectious diseases. Analysis shows MHC class II binding peptides of antigen protein from Trichinella spiralis are important determinant for protection of host form parasitic infection. In this assay, we used PSSM and SVM algorithms for antigen design and predicted the binding affinity of antigen protein having 439 amino acids, which shows 432 nonamers. Binding ability prediction of antigen peptides to major histocompatibility complex (MHC) class I & II molecules is important in vaccine development from Trichinella spiralis.

<

Introduction

Trichinella species are the smallest nematode parasite of humans, have an unusual life cycle and are one of the most widespread and clinically important parasites in the world [1]. The small adult worms mature in the intestines of an intermediate host such as a pig [1,2]. Trichinella spiralis antigen peptides are most suitable for subunit vaccine development because with single epitope, the immune response can be generated in large population. This approach is based on the phenomenon of cross-protection, whereby infected with a mild strain and is protected against a more severe strain of the same. The phenotype of the resistant transgenic hosts includes fewer centers of initial infection, a delay in symptom development, and low accumulation. Antigen protein from Trichinella spiralis is necessary for new paradigm of synthetic vaccine development and target validation [3-5].

Methodology

In this research work antigenic epitopes of antigen protein from Trichinella spiralis is determined using the Gomase in 2007, Welling, Eisenberg, Parker and Chou & Fasman and Levitt antigenicity [6-8]. The major histocompatibility complex (MHC) peptide binding of antigen protein is predicted using neural networks trained on C terminals of known epitopes. In analysis predicted MHC/peptide binding of antigen protein is a log-transformed value related to the IC50 values in nM units. MHC2Pred predicts peptide binders to MHCI and MHCII molecules from protein sequences or sequence alignments using Position Specific Scoring Matrices (PSSMs). Support Vector Machine (SVM) based method for prediction of promiscuous MHC class II binding peptides. SVM has been trained on the binary input of single amino acid sequence [9-14]. In addition, we predict those MHC ligands from whose C-terminal end is likely to be the result of proteosomal cleavage [15-18].

Results and Interpretations

We found binding of peptides to a number of different alleles using Position Specific Scoring Matrix. An antigen protein sequence is 44 residues long, having antigenic MHC binding peptides. MHC molecules are cell surface glycoproteins, which take active part in host immune reactions and involvement of MHC class-I and MHC II in response to almost all antigens. PSSM based server predict the peptide binders to MHCI molecules of antigen protein sequence are as 11mer_H2_Db, 10mer_H2_Db, 9mer_H2_Db, 8mer_H2_Db and also peptide binders to MHCII molecules of antigen protein sequence as I_Ab. p, I_Ad. p, analysis found antigenic epitopes region in putative antigen protein (Table 1). We also found the SVM based MHCII-IAb peptide regions; MHCII-IAd peptide regions; MHCII-IAg7 peptide regions and MHCII- RT1. B peptide regions, which represented predicted binders from bacterial antigen protein (Table 2). The predicted binding affinity is normalized by the 1% fractil. We describe an improved method for predicting linear epitopes (Table 2). The region of maximal hydrophilicity is likely to be an antigenic site, having hydrophobic characteristics, because terminal regions of antigen protein is solvent accessible and unstructured, antibodies against those regions are also likely to recognize the native protein (Figures 1, 2, 3). It was shown that a antigen protein is hydrophobic in nature and contains segments of low complexity and high-predicted flexibility (Figures 4, 5). Predicted antigenic fragments can bind to MHC molecule is the first bottlenecks in vaccine design.

MHC-I POS. N Sequence C MW (Da) Score % OPT.
8mer_H2_Db 220 LNE LEEDFRTI LSI 1004.12 16.314 31.08 %
8mer_H2_Db 95 RQV AQYNNFSI FSK 938.01 13.407 25.54 %
8mer_H2_Db 44 ICQ FNLRCLEF LKS 1023.23 9.894 18.85 %
8mer_H2_Db 38 KAV PSLICQFN LRC 903.07 9.7 18.48 %
8mer_H2_Db 139 DHL PINPEVKI SNG 891.08 8.916 16.98 %
8mer_H2_Db 322 PVS RKAGPMTY QML 905.08 8.704 16.58 %
8mer_H2_Db 96 QVA QYNNFSIF SKK 1014.11 8.63 16.44 %
9mer_H2_Db 63 EMY FMLCLIDHI ISN 1086.38 20.064 39.84 %
9mer_H2_Db 95 RQV AQYNNFSIF SKK 1085.19 19.926 39.56 %
9mer_H2_Db 130 MEL FAHWSKDHL PIN 1099.25 19.277 38.27 %
9mer_H2_Db 44 ICQ FNLRCLEFL KSY 1136.39 15.072 29.93 %
9mer_H2_Db 41 PSL ICQFNLRCL EFL 1091.36 13.216 26.24 %
9mer_H2_Db 38 KAV PSLICQFNL RCL 1016.23 11.437 22.71 %
9mer_H2_Db 184 GYD QLIKNAREL YTE 1066.27 11.399 22.63 %
10mer_H2_Db 306 VSP SILKPLADYG ILN 1058.25 22.969 39.02 %
10mer_H2_Db 94 FRQ VAQYNNFSIF SKK 1184.32 19.021 32.32 %
10mer_H2_Db 73 HII SNYEPFRKGF ATK 1226.37 16.158 27.45 %
10mer_H2_Db 95 RQV AQYNNFSIFS KKN 1172.27 16.055 27.28 %
10mer_H2_Db 206 SIF NGEINEKEKA ELN 1113.19 15.416 26.19 %
10mer_H2_Db 9 LVK SAIDNEEVNP SLH 1069.1 11.88 20.18 %
10mer_H2_Db 70 LID HIISNYEPFR KGF 1257.43 11.82 20.08 %
11mer_H2_Db 94 FRQ VAQYNNFSIFS KKN 1271.4 13.696 17.23 %
11mer_H2_Db 285 DYS KTETNYESYPV QRE 1312.4 10.441 13.13 %
11mer_H2_Db 322 PVS RKAGPMTYQML EDD 1277.56 9.568 12.04 %
11mer_H2_Db 57 SYI SRKEMYFMLCL IDH 1402.76 9.078 11.42 %
11mer_H2_Db 39 AVP SLICQFNLRCL EFL 1291.6 7.777 9.78 %
11mer_H2_Db 8 ELV KSAIDNEEVNP SLH 1197.27 6.901 8.68 %
11mer_H2_Db 58 YIS RKEMYFMLCLI DHI 1428.84 6.462 8.13 %

Table 1: PSSM based prediction of MHC ligands, from whose C-terminal end are proteosomal cleavage sites.

MHC ALLELE Rank Sequence Residue No. Peptide Score
I-Ab 1 PYYLNRLPV 33 1.093
I-Ab 2 VKQKDVKPK 195 0.747
I-Ab 3 PDTSDNRVR 65 0.719
I-Ab 4 LHLKVKAEV 308 0.685
I-Ad 1 GSSNSCQTR 276 0.642
I-Ad 2 EEFEIGDFC 248 0.629
I-Ad 3 HEASVLAAE 393 0.584
I-Ad 4 QASARETEA 415 0.499
I-Ag7 1 RFYAEYRML 378 1.786
I-Ag7 2 VLAAEHDVA 397 1.345
I-Ag7 3 TGVADIYTI 260 1.323
I-Ag7 4 ISQASARET 413 1.269
RT1.B 1 ISQASARET 413 1.127
RT1.B 2 DFRKAQQLI 354 0.919
RT1.B 3 TVSKQYPYQ 293 0.817
RT1.B 4 KTEETSTLP 324 0.807

Table 2: SVM based prediction of promiscuous MHC class II binding peptides from antigen protein.

Figure

Figure 1: Hydrophobicity plot of antigen protein by Hphob / Welling & al., scale.

drug-designing-antigen-protein

Figure 2: Hydrophobicity plot of antigen protein by Hphob/ Eisenberg, et al., scale.

drug-designing-Hydrophobicity-plot

Figure 3: Hydrophobicity plot of antigen protein by Hphob. HPLC /Parker & et al., scale.

drug-designing-Antigenicity-plot

Figure 4: Antigenicity plot of antigen protein by Hphob. / Rao & Argos, scale.

drug-designing-Beta-Sheet

Figure 5: Antigenicity plot of antigen protein by Beta-Sheet / Levitt scale.

Conclusion

An antigen protein from Trichinella spiralis peptide nonamers are from a set of aligned peptides known to bind to a given MHC molecule as the predictor of MHC-peptide binding. MHCII molecules bind peptides in similar yet different modes and alignments of MHCII-ligands were obtained to be consistent with the binding mode of the peptides to their MHC class, this means the increase in affinity of MHC binding peptides may result in enhancement of immunogenicity of antigen protein. These predicted of antigen protein antigenic peptides to MHC class molecules are important in vaccine development from Trichinella spiralis

References

  1. Wu XP, Fu BQ, Wang XL, Yu L, Yu SY, et al. (2009) Identification of antigenic genes in Trichinella spiralis by immunoscreening of cDNA libraries. Vet Parasitol 159: 272-275.
  2. Zocevic A, Mace P, Vallee I, Blaga R, Liu M, et al. (2011) Identification of Trichinella spiralis early antigens at the pre-adult and adult stages. Parasitology 138: 463-471.
  3. Mitreva M, Appleton J, McCarter JP, Jasmer DP (2005) Expressed sequence tags from life cycle stages of Trichinella spiralis: application to biology and parasite control. Vet Parasitol 132: 13-17.
  4. McDonald D, Stockwin L, Matzow T, Blair Zajdel ME, Blair GE (1999) Coxsackie and adenovirus receptor (CAR)-dependent and major histocompatibility complex (MHC) class I-independent uptake of recombinant adenoviruses into human tumour cells. Gene Ther 6: 1512-1519.
  5. Gomase VS, Kale KV. Shyamkumar K (2008) Prediction of MHC Binding Peptides and Epitopes from Groundnut Bud Necrosis Virus (GBNV J Proteomics Bioinform 1: 188- 205.
  6. Gomase VS, Kale KV, Chikhale NJ, Changbhale SS (2007) Prediction of MHC binding peptides and epitopes from alfalfa mosaic virus. Curr Drug Discov Technol 4: 117-215.
  7. Gomase VS, Kale KV (2008) In silico prediction of epitopes: a new approach for fragment based viral peptide vaccines. Int J of Applied Computing 1: 39-46.
  8. Gomase VS, Kale KV (2008) Approach of proteomics system architecture in plant virus’s database. Int J of Applied Computing 1: 33-38.
  9. Gomase VS, Kapoor RA, Ladak SS (2010) Eimeria acervulina analysis for binding peptides using protein profiling for target validation. International Journal of Machine Intelligence 2: 01-08.
  10. Gomase VS, Kale KV, Shyamkumar K, Shankar S (2008) Computer Aided Multi Parameter Antigen Design: Impact of Synthetic Peptide Vaccines from Soybean Mosaic Virus. ICETET 2008, IEEE Computer Society in IEEE Xplore, Los Alamitos, California, 629-634.
  11. Gomase VS, Tandale JP, Patil SA, Kale KV (2006) Automatic modeling of protein 3D structure Nucleoplasmin-like viral coat protein from Cucumber mosaic virus. 14th International Conference on Advance Computing & Communication, Published by IEEE Computer Society in IEEE Xplore USA 614-615.
  12. Reche PA, Glutting JP, Reinherz EL (2002) Prediction of MHC class I binding peptides using profile motifs. Hum Immunol 63: 701-709.
  13. Buus S, Lauemøller SL, Worning P, Kesmir C, Frimurer T, et al. (2003) Sensitive quantitative predictions of peptide-MHC binding by a 'Query by Committee' artificial neural network approach. Tissue Antigens 62: 378-384.
  14. Nielsen M, Lundegaard C, Worning P, Lauemøller SL, Lamberth K, et al. (2003) Reliable prediction of T-cell epitopes using neural networks with novel sequence representations. Protein Sci 12: 1007-1017.
  15. Bhasin M, Raghava GP (2005) Pcleavage: an SVM based method for prediction of constitutive proteasome and immunoproteasome cleavage sites in antigenic sequences. Nucleic Acids Res 33: W202-207.
  16. Gomase VS, Kapoor RA, Ladak SS (2010) Immuno-proteomics approach for synthetic vaccine development form Haemophilus influenzae. Journal of Infectious Diseases Letters, 1: 01-06.
  17. Gomase VS, Shyamkumar K (2009) Prediction of antigenic epitopes and MHC binders of neurotoxin alpha-KTx 3.8 from Mesobuthus tamulus sindicus. AJB 8: 6658-6676.
  18. Gomase VS, Kapoor KA, Ladak SS Computer intelligence approach for prediction of biding ability and fragment based peptide vaccines from Leishmania protozoa peptides. Software and Computing Technology, ICSCT 2010, IEEE Computer Society in IEEE Xplore, USA.
Citation: Gomase VS, Chitlange NR (2012) Sensitive Quantitative Predictions of mhc Binding Peptides and Fragment Based Peptide Vaccines From Trichinella spiralis. Drug Design 1:101.

Copyright: © 2012 Gomase VS, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Top